 |
Shridar Ganesan, M.D., Ph.D.
Shridar Ganesan, M.D., Ph.D. was recruited to Rutgers Cancer Institute of New Jersey in June 2006 as an Assistant Professor. He is currently an Associate Professor of Medicine and Pharmacololgy, serves as Associate Director of Translational Science and is a key member of the leadership team at the Cancer Institute. In addition, Omar Boraie Chair in Genomic Science He is a respected researcher in cancer biology, a respected teacher and mentor, and a compassionate physician.
He graduate from Princeton University summa cum laude, and went on to receive and Ph.D. in Cell Biology and an M.D. at Yale University. He trained in internal medicine at the Brigham and Women’s Hospital in Boston, MA, where he served as Chief Medical Resident, and pursued a fellowship in medical oncology at the Dana Farber Cancer Institute. He had post-doctoral training in the laboratory of Dr. David Livingston where he studied the biology of BRCA1 breast cancer gene and its role in DNA repair and chromatin modulation. He joined the faculty of Harvard Medical School as an Instructor in Medicine and as a Staff Physician at the Dana Farber Cancer Institute.
When recruited to the Cancer Institute of New Jersey as a physician-scientist, he set up an independent research laboratory focused on DNA repair, breast cancer biology, and cancer genomics. This work has been highly productive, leading to over 60 publications in journals such as Science, Cell, Cancer Cell, Cancer Research, Nature Structural and Molecular Biology, and has resulted in funding from the National Institutes of Health, the Sidney Kimmel Foundation, the Triple Negative Breast Cancer Foundation, the Century for the Cure and Hugs for Brady. He is considered an expert in DNA repair and breast cancer biology and has been invited to give lectures at major national and international cancer centers and meetings. He serves as a grant reviewer for the NCI and DoD, and reviews articles for many scientific journals.
His clinical work is focused on breast cancers and rare cancers. He sees patients in the Stacy Goldstein Breast Cancer Center. He has a special interest in the biology and treatment of triplenegative breast cancers and BRCA1/2 associated breast cancers, and participates in many clinical trials in breast caner. Dr. Ganesan has been an invited speaker at major clinical and scientific breast cancer meetings including the San Antonio Breast Caner Symposium and the Americal Association of Cancer Research. He also is a critical driver of the Precision Medicine Initiative at the Cancer Institute, and has developed a research protocol in which patients with rare or difficult to treat cancers under targeted genomic sequencing to search for new potential treatment options. He has been instrumental in developing the Molecular Tumor Board at RCINJ and the new Molecular Therapeutics Clinic at Rutgers CINJ. This work has led to several novel findings that are driving both clinical trials and basic cancer research at the Cancer Institute.
Dr. Ganesan also contributes to teaching at Rutgers at multiple levels. He serves as the Assistant Director of the Joint MD-Ph.D. program of Rutgers/Princeton. He give popular lectures on cancer biology to undergraduates, graduate students, medical students and oncology fellows at Princeton University and Rutgers University and serves as primary research mentor for graduate students and post-doctoral fellows in his laboratory.
Dr. Ganesan lives in Westfield, NJ with his wife Anushua Sinha and his daughter Gayatri Sinha Ganesan. |
